Home
Categories
Design & Build
Patient Experience
Estates & Facilities
Technology
Mental Health
Social Care
Sustainability
Furniture & Fixtures
Digital
Infection Control
Medical Devices
Regulatory
BBH Awards
Company News
Events
Directory
Search
Close search
Home
Company
Deontics
Deontics
Activities:
Digital
Share
X
LinkedIn
Trending Articles
£19.1m project win: Morgan Sindall confirmed for Milton Keynes University Hospital
Morgan Sindall Construction has been appointed to develop Milton Keynes University Hospital’s new £19.1m ward expansion
Meet the Building Better Healthcare Awards judges for 2024
This year's judging panel includes architects, directors, healthcare leaders, chief executives, experts and presidents
London NHS Trusts plan merger: The North Mid and Royal Free London aim for Autumn deadline
North Middlesex University Hospital NHS Trust and the Royal Free London NHS Foundation Trust have been clinical partners since 2017 and are now exploring becoming one organisation
St Margaret’s Hospital submits application for Community Diagnostic Centre
The hospital which sits within Epping Forest District Council has reached a significant milestone in submitting planning application
New Velindre Cancer Centre chooses Kier as facilities management provider
Kier, as part of the ACORN consortium, has been appointed to deliver facilities management services for the new Velindre Cancer Centre in Cardiff upon the completion of its...
Upcoming event
HEFMA Leadership Forum
8–10 May 2024 | Conference, exhibition and awards | Telford, UK
See all
Related Content
Digital
Pioneering trust uses AI to help doctors make the right treatment decisions
Royal Liverpool and Broadgreen University Hospitals NHS Trust working with Deontics to enhance clinical decision making and reduce risk of heart attacks
Digital
Capital's medtech companies triumph at Mayor's awards
Five innovative technologies singled out at London MedTech Business Awards
Digital
Nick Beard appointed non-executive director at Deontics
Artificial intelligence health company adds board member to promote growth in evidence-based and personalised medicine markets in US and UK
Subscribe now